Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

Published:2017-11-07 Issue:17 Volume:318 Page:1679
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Lemaitre Magali¹,Kirchgesner Julien²,Rudnichi Annie¹,Carrat Fabrice³,Zureik Mahmoud¹,Carbonnel Franck⁴,Dray-Spira Rosemary¹

Affiliation:

1. Department of Epidemiology, Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM), Saint-Denis, France

2. Department of Epidemiology, Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM), Saint-Denis, France2Sorbonne Universités, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, UMR_S 1136, F-75012, Paris, France3Department of Gastroenterology, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France

3. Sorbonne Universités, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, UMR_S 1136, F-75012, Paris, France4Department of Public Health, Hôpital Saint Antoine, AP-HP, F-75012, Paris, France

4. Department of Gastroenterology, Hôpitaux Universitaires Paris Sud, Assistance Publique-Hôpitaux de Paris, Université Paris-Sud, Le Kremlin Bicêtre, France

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 455 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 6‐Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy;Internal Medicine Journal;2024-09-05

2. Should the Dermatological Assessment of Patients with Inflammatory Bowel Disease Become Standard during Qualifications for Biological Treatment? A Retrospective, Single-Center Experience from a Tertiary Center;Journal of Clinical Medicine;2024-09-02

3. Factors Associated With Decision to Treat or Not to Treat Helicobacter pylori Infection in Children: Data From the EuroPedHp Registry;Helicobacter;2024-09

4. Malignancy, a real risk in patients using anti-TNF drugs for Crohn’s disease?;Journal of Case Reports and Images in Pathology;2024-08-29

5. Epithelial barrier dysfunction and microbial dysbiosis: exploring the pathogenesis and therapeutic strategies for Crohn’s disease;Tissue Barriers;2024-08-26